E-GEOD-59037
Ontology highlight
ABSTRACT:
OTHER RELATED OMICS DATASETS IN: PRJNA254172
PROVIDER: E-GEOD-59037 | ExpressionAtlas | 2015-08-04
REPOSITORIES: ExpressionAtlas
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| E-GEOD-59037-analysis-methods.tsv | Tabular | |||
| E-GEOD-59037-atlasExperimentSummary.Rdata | Rdata | |||
| E-GEOD-59037-configuration.xml | Xml | |||
| E-GEOD-59037-percentile-ranks.tsv | Tabular | |||
| E-GEOD-59037.condensed-sdrf.tsv | Tabular |
Items per page: 5 1 - 5 of 49 |
Similar Datasets
Project description:Dissecting engineered cell types and enhancing cell fate conversion via CellNet
| PRJNA254172 | ENA
Project description:Neurogenic microRNAs 9/9* and 124 (miR-9/9*-124) drive the direct reprogramming of human fibroblasts into neurons with the initiation of the fate erasure of fibroblasts. However, whether the miR-9/9*-124 fate erasure logic extends to neuronal conversion of other somatic cell types remains unknown. Here, we uncover that miR-9/9*-124 induce neuronal conversion of multiple cell types: dura fibroblasts, astrocytes, smooth muscle cells, and pericytes. We reveal the cell type-specific and pan-somatic gene network erasure induced by miR-9/9*-124, including cell cycle, morphology, and proteostasis gene networks. Leveraging these pan-somatic gene networks, we predict upstream regulators that may antagonize somatic fate erasure. Among the predicted regulators, we identify TP53 (p53) whose inhibition is sufficient to enhance neuronal conversion even in post-mitotic cells. This study extends miR-9/9*-124 reprogramming to alternate somatic cells, reveals the pan-somatic gene network fate erasure logic of miR-9/9*-124, and shows a neurogenic role for p53-inhibition in the miR-9/9*-124-signaling cascade.
2024-12-31 | GSE283009 | GEO
Project description:MS analysis to provide insights into proteins bound to engineered cell fate regulator NanogBiD during somatic cell reprogramming
2023-10-09 | PXD046008 |
Project description:RNA-seq of different tissues and xylem cell types of Populus trichocarpa to study wood formation
2019-01-09 | E-GEOD-81077 | ExpressionAtlas
Project description:Direct conversion generates patient-specific, disease-relevant cell types such as neurons that are rare, limited, or difficult to isolate from common and easily accessible cells such as skin cells. However, low rates of direct conversion and complex protocols limit scalability and thus the potential of cell-fate conversion for biomedical applications. Systems-level optimization of conversion protocols across molecular and cellular scales can support scalable cell manufacturing for diverse application. We use insights from our work on how proliferation and transcription factor levels act together to drive direct conversion to optimize the conversion protocol by examining process parameters including transcript design, delivery via AAV, retrovirus and lentivirus, cell seeding density, and the impact of media conditions. Thus, we report a compact, portable conversion process that boosts proliferation and increases direct conversion of mouse fibroblasts to induced motor neurons to achieve high conversion rates of above 1,000%, corresponding to more than 10 motor neurons yielded per cell seeded which we achieve through expansion. Our optimized, direct conversion process generates functional motor neurons at scales relevant for cell therapies (>10^7 cells) that graft with the mouse central nervous system. High-efficiency, compact, direct conversion systems will support scaling to patient-specific, neural cell therapies.
2025-02-03 | GSE287882 | GEO
Project description:Direct conversion generates patient-specific, disease-relevant cell types such as neurons that are rare, limited, or difficult to isolate from common and easily accessible cells such as skin cells. However, low rates of direct conversion and complex protocols limit scalability and thus the potential of cell-fate conversion for biomedical applications. Systems-level optimization of conversion protocols across molecular and cellular scales can support scalable cell manufacturing for diverse application. We use insights from our work on how proliferation and transcription factor levels act together to drive direct conversion to optimize the conversion protocol by examining process parameters including transcript design, delivery via AAV, retrovirus and lentivirus, cell seeding density, and the impact of media conditions. Thus, we report a compact, portable conversion process that boosts proliferation and increases direct conversion of mouse fibroblasts to induced motor neurons to achieve high conversion rates of above 1,000%, corresponding to more than 10 motor neurons yielded per cell seeded which we achieve through expansion. Our optimized, direct conversion process generates functional motor neurons at scales relevant for cell therapies (>107 cells) that graft with the mouse central nervous system. High-efficiency, compact, direct conversion systems will support scaling to patient-specific, neural cell therapies.
2025-02-03 | GSE287783 | GEO
Project description:Human immunochemistry data on 83 different normal cell types from 44 tissue types from the Human Protein Atlas project
2025-01-21 | E-PROT-3 | ExpressionAtlas
Project description:Neurogenic microRNAs 9/9* and 124 (miR-9/9*-124) drive the direct reprogramming of human fibroblasts into neurons with the initiation of the fate erasure of fibroblasts. However, whether the miR-9/9*-124 fate erasure logic extends to neuronal conversion of other somatic cell types remains unknown. Here, we uncover that miR-9/9*-124 induce neuronal conversion of multiple cell types: dura fibroblasts, astrocytes, smooth muscle cells, and pericytes. We reveal the cell type-specific and pan-somatic gene network erasure induced by miR-9/9*-124, including cell cycle, morphology, and proteostasis gene networks. Leveraging these pan-somatic gene networks, we predict upstream regulators that may antagonize somatic fate erasure. Among the predicted regulators, we identify TP53 (p53) whose inhibition is sufficient to enhance neuronal conversion even in post-mitotic cells. This study extends miR-9/9*-124 reprogramming to alternate somatic cells, reveals the pan-somatic gene network fate erasure logic of miR-9/9*-124, and shows a neurogenic role for p53-inhibition in the miR-9/9*-124-signaling cascade.
2024-12-31 | GSE283008 | GEO
Project description:Neurogenic microRNAs 9/9* and 124 (miR-9/9*-124) drive the direct reprogramming of human fibroblasts into neurons with the initiation of the fate erasure of fibroblasts. However, whether the miR-9/9*-124 fate erasure logic extends to neuronal conversion of other somatic cell types remains unknown. Here, we uncover that miR-9/9*-124 induce neuronal conversion of multiple cell types: dura fibroblasts, astrocytes, smooth muscle cells, and pericytes. We reveal the cell type-specific and pan-somatic gene network erasure induced by miR-9/9*-124, including cell cycle, morphology, and proteostasis gene networks. Leveraging these pan-somatic gene networks, we predict upstream regulators that may antagonize somatic fate erasure. Among the predicted regulators, we identify TP53 (p53) whose inhibition is sufficient to enhance neuronal conversion even in post-mitotic cells. This study extends miR-9/9*-124 reprogramming to alternate somatic cells, reveals the pan-somatic gene network fate erasure logic of miR-9/9*-124, and shows a neurogenic role for p53-inhibition in the miR-9/9*-124-signaling cascade.
2024-12-31 | GSE283006 | GEO
Project description:Neurogenic microRNAs 9/9* and 124 (miR-9/9*-124) drive the direct reprogramming of human fibroblasts into neurons with the initiation of the fate erasure of fibroblasts. However, whether the miR-9/9*-124 fate erasure logic extends to neuronal conversion of other somatic cell types remains unknown. Here, we uncover that miR-9/9*-124 induce neuronal conversion of multiple cell types: dura fibroblasts, astrocytes, smooth muscle cells, and pericytes. We reveal the cell type-specific and pan-somatic gene network erasure induced by miR-9/9*-124, including cell cycle, morphology, and proteostasis gene networks. Leveraging these pan-somatic gene networks, we predict upstream regulators that may antagonize somatic fate erasure. Among the predicted regulators, we identify TP53 (p53) whose inhibition is sufficient to enhance neuronal conversion even in post-mitotic cells. This study extends miR-9/9*-124 reprogramming to alternate somatic cells, reveals the pan-somatic gene network fate erasure logic of miR-9/9*-124, and shows a neurogenic role for p53-inhibition in the miR-9/9*-124-signaling cascade.
2024-12-31 | GSE283004 | GEO